107 
In previous guidance provided by CogState in April 2010, it was indicated that June quarter sales revenue would be impacted by some delays in commencement of a small number of clinical trials by our customers. The guidance went on to note that actual results could be impacted by new sales contracts signed before 30 J… Read all
Cogstate Full year results
|
Cochlear Full-Year Net Income Climbs 19% on Demand for new product release
Cochlear Ltd., maker of the world’s best-selling hearing implant, posted a 19 percent gain in full- year profit on demand for its newest product. Net income climbed to A$155.2 million ($142 million) in the 12 months ended June 30, from A$130.5 million a year earlier, Sydney-based Cochlear said today. Analysts proje… Read all |
ResMed FY profit lifts
ResMed FY profit lifts Medical equipment manufacturer ResMed Inc Ltd says it sees continued growth in its operating areas after posting a 30 per cent rise in net profit for the full year. ResMed, which manufactures sleeping and respiratory aids, posted a net profit of $US190.1 million ($207.8 million) … Read all |
Stirling acquires 65% interest in TeleMedCare
Stirling Products Ltd has acquired a 65% controlling interest in remote patient monitoring equipment company TeleMedCare Holdings Pty Ltd, which is in administration. TeleMedCare operates in Australia and the UK but intends to expand in other countries. Creditors of TeleMedCare and a wholly-owned subsidiary have appr… Read all |
 |
Phylogica in trading halt
|
Sigma attracts new bidder for generics
California-based Watson Pharmaceuticals Ltd is considering a bid for Sigma Pharmaceuticals Ltd's generics business, Fairfax media reports. Watson, a specialty healthcare company, has been looking at the $600 million division after Sigma experienced a series of profit downgrades, Fairfax reported. Sigma is curre… Read all |
Terms & Rules
As per ASIC Regulatory Guide 162: All investment tips and comments appearing on this website (Poll results, BLOGS & discussion forums) are submitted by the general public who are not licensed financial advisors. None of the information on this website is financial or investment advice, you should seek independent financial or investment advice by a licensed financial or investment advisor before entering into any position of financial risk. Before using this website, you must agree to the BioInvesting.com.au Terms Of Use